Pharmacyclics (PCYC) Announces Management Shift; Jesse McGreivy to Medical Chief
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Join SI Premium – FREE
On July 9, 2013, Pharmacyclics, Inc. (Nasdaq: PCYC) made the following promotions: Jesse McGreivy, MD, to Chief Medical Officer; Darrin Beaupre, MD, to Vice President of Clinical Medicine and Early Development; Thorsten Graef, MD, to Vice President of Clinical Science; and Betty Chang, Ph.D., to Vice President of Research/Biology.
Also on July 9, 2013, David Loury, Ph.D., was appointed to the position of Executive Vice President of Toxicology and will no longer hold the position of Chief Scientific Officer; Lori Kunkel, MD, will remain with the Company and will no longer hold the position of Chief Medical Officer; and Joe Buggy, Ph.D., announced his intention to resign as the Company’s Vice President of Research, and will remain with the Company for an indefinite period of time at the Company’s request.
Also on July 9, 2013, David Loury, Ph.D., was appointed to the position of Executive Vice President of Toxicology and will no longer hold the position of Chief Scientific Officer; Lori Kunkel, MD, will remain with the Company and will no longer hold the position of Chief Medical Officer; and Joe Buggy, Ph.D., announced his intention to resign as the Company’s Vice President of Research, and will remain with the Company for an indefinite period of time at the Company’s request.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- loanDepot (LDI) Appoints Jeff Wilkish as Regional VP for New England
- HF Foods Group (HFFG) Appoints Cindy Yao as CFO
- WNS Holdings (WNS) Announces CFO Transition
Create E-mail Alert Related Categories
Hot Corp. News, Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
